Memorial Sloan Kettering Cancer Center Commack: Clinical Trials at Commack

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan Kettering Cancer Center Commack below. You can also explore our complete listing of clinical trials available at Memorial Sloan Kettering.

Showing 41 - 60 of 122 trials
Title Investigatorsort icon Disease(s)
Ofatumumab with or without Bendamustine for Patients with Mantle Cell Lymphoma Who Cannot Have an Autologous Stem Cell Transplant
Newly Diagnosed
[Protocol 11-050]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma
[Protocol 13-028]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
Newly Diagnosed
[Protocol 12-018]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of Bortezomib/Dexamethasone Followed by Lenalidomide in Nonresponders as Initial Treatment for Multiple Myeloma
[Protocol 13-064]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of Lenalidomide and Low-Dose Dexamethasone (LD) Followed by Continued LD or Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma
[Protocol 08-121]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Pilot Study of Bortezomib/Dexamethasone Followed by Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone for the Initial Treatment of MIDD Associated with Multiple Myeloma and Amyloidosis
Newly Diagnosed
[Protocol 11-061]
Hassoun, Hani
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
    • Multiple Myeloma
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
Newly Diagnosed
[Protocol 11-107]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase III Study of Gemcitabine, Docetaxel, and Doxorubicin versus Observation in Women with High-Grade Uterine Leiomyosarcoma
[Protocol 12-177]
Hensley, Martee
  • Uterine Sarcoma
    • Leiomyosarcoma
A Phase II Study of Regorafenib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
[Protocol 13-244]
Ho, Alan
  • Head & Neck Cancer
A Phase II Study of Multi-Beam Intensity-Modulated Radiation Therapy for Patients with Locally Advanced Breast Cancer Who Had Implant Reconstruction
[Protocol 14-028]
Ho, Alice
  • Breast Cancer
A Phase II Study of Romidepsin after Autologous Stem Cell Transplantation in Patients with T-Cell Non-Hodgkin Lymphoma
[Protocol 13-020]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
Relapsed/Refractory
[Protocol 12-170]
Horwitz, Steven
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgery in Patients with Locally Advanced Thymoma
[Protocol 09-038]
Huang, James
  • Thymoma
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131]
Hyman, David
  • Hematology
    • Hematologic Disorders
    • Multiple Myeloma
  • Rare Blood Disorders
A Phase II Study of Dasatinib to Treat Recurrent Clear Cell Cancer of the Ovaries or Endometrium
[Protocol 14-008]
Hyman, David
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011]
Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer
[Protocol 06-103]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase II Study of FOLFOX plus Regorafenib in Patients with Inoperable or Metastatic Esophageal and/or Stomach Cancer
[Protocol 13-080]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Nintedanib in Patients with Advanced Esophagogastric Cancer
[Protocol 14-094]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase III Study of Actinomycin-D versus Methotrexate to Treat Low-Risk Gestational Trophoblastic Disease
[Protocol 13-108]
Jewell, Elizabeth
  • Uterine (Endometrial) Cancer